About this trial
The purpose of this study is to strengthen our ability to accurately diagnose allergies and understand cellular, humoral, genetic components and physiological changes in allergic disease
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Any individual with possible allergy
Disqualifiers
Patients with special risks attendant to venipuncture will be excluded
Trial population
Patients ages 1 week through 90 years who have or are suspected of having allergic sensitivities will be invited to participate
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Skin testing to evaluate food allergen responses
Standardized skin testing performed to detect sensitivity to allergens of interest
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Stanford University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
Crown Fundation
Collaborator
Sunshine Foundation
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
National Human Genome Research Institute (NHGRI)
Collaborator
Harvard School of Public Health (HSPH)
Collaborator